AI
IBB icon

ArchPoint Investors’s iShares Biotechnology ETF IBB Stock Holding History

ArchPoint Investors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.83M Hold
16,750
– – 0.67% 35
2025
Q4 		$2.83M Hold
16,750
– – 0.67% 36
2025
Q3 		$2.42M Hold
16,750
– – 0.66% 36
2025
Q2 		$2.12M Hold
16,750
– – 0.62% 36
2025
Q1 		$2.14M Buy
16,750
+750
+5% +$102K 0.7% 33
2024
Q4 		$2.12M Sell
16,000
-750
-4% -$105K 0.69% 32
2024
Q3 		$2.44M Hold
16,750
– – 0.81% 30
2024
Q2 		$2.3M Hold
16,750
– – 0.86% 35
2024
Q1 		$2.3M Buy
+16,750
New +$2.29M 0.96% 30
2020
Q2 		– Sell
-6,180
Closed -$666K – 121
2020
Q1 		$666K Sell
6,180
-960
-13% -$111K 0.26% 41
2019
Q4 		$860K Sell
7,140
-495
-6% -$55.2K 0.26% 45
2019
Q3 		$760K Sell
7,635
-300
-4% -$31.4K 0.26% 38
2019
Q2 		$866K Sell
7,935
-22,200
-74% -$2.36M 0.27% 37
2019
Q1 		$3.37M Sell
30,135
-138
-0.5% -$15.1K 1.01% 20
2018
Q4 		$2.92M Sell
30,273
-34,800
-53% -$3.69M 1.01% 23
2018
Q3 		$7.94M Hold
65,073
– – 2.16% 9
2018
Q2 		$7.16M Hold
65,073
– – 2.06% 9
2018
Q1 		$6.95M Hold
65,073
– – 2.05% 8
2017
Q4 		$6.95M Hold
65,073
– – 2.17% 9
2017
Q3 		$7.24M Hold
65,073
– – 2.31% 7
2017
Q2 		$6.73M Sell
65,073
-7,092
-10% -$698K 2.14% 7
2017
Q1 		$7.05M Buy
72,165
+360
+0.5% +$34.5K 2.65% 7
2016
Q4 		$6.35M Buy
71,805
+40,350
+128% +$3.67M 3.74% 5
2016
Q3 		$3.04M Buy
31,455
+30,000
+2,062% +$2.85M 1.73% 16
2016
Q2 		$125K Hold
1,455
– – 0.07% 93
2016
Q1 		$126K Buy
1,455
+225
+18% +$20.1K 0.07% 84
2015
Q4 		$139K Buy
+1,230
New +$134K 0.1% 82

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

ArchPoint Investors's IBB Position: Q1 2026 in Review

ArchPoint Investors held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 16,750 shares worth $2.83M. The position accounts for 0.67% of the portfolio, ranked #35.

ArchPoint Investors first reported a position in IBB in Q4 2015 and has held it in 27 quarters since. The position peaked at $7.94M in Q3 2018. 918 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • ArchPoint Investors held 16,750 shares of iShares Biotechnology ETF worth $2.83M as of Q1 2026.
  • ArchPoint Investors left its iShares Biotechnology ETF share count unchanged in Q1 2026.
  • iShares Biotechnology ETF made up 0.67% of ArchPoint Investors's portfolio in Q1 2026, its #35 holding.
  • ArchPoint Investors first reported a position in iShares Biotechnology ETF in Q4 2015 and has held it in 27 quarters since.
  • ArchPoint Investors's iShares Biotechnology ETF position peaked at $7.94M in Q3 2018.
  • 918 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on ArchPoint Investors's 13F filing for Q1 2026, filed 14 May 2026.